SHOULDER INNOVATIONS, INC. 8-K

What Happened

• Shoulder Innovations, Inc. announced on March 2, 2026 (8-K filing) that Class I director Geoff Pardo resigned effective February 26, 2026. His resignation also removed him from the Compensation Committee and as Chair of the Nominating and Corporate Governance Committee; the company states the resignation was not due to any disagreement with management or the Board.
• On the same date, the Board appointed Andrew Hykes (age 53) as a Class I director and as a member of the Compensation Committee, effective immediately. The Board determined Mr. Hykes is an independent director and meets applicable NYSE and Exchange Act requirements for Compensation Committee membership.

Key Details

• Resignation date: February 26, 2026; 8-K filed March 2, 2026.
• New director: Andrew Hykes, age 53; appointed to fill Mr. Pardo’s Class I seat and to serve on the Compensation Committee.
• Mr. Hykes’ background: CEO of Okami Medical since Oct 2025; CEO of Inari Medical (Jan 2023–May 2025); prior roles at Inari (COO, CCO), Sequent Medical, and Medtronic; B.B.A. University of Wisconsin–Madison, M.B.A. Harvard Business School.
• Compensation and governance: Mr. Hykes will be paid under the company’s existing Non-Employee Director Compensation Program and will sign the company’s standard director indemnification agreement; no related-party transactions reported.

Why It Matters

• Board composition and committee membership changed immediately, which can affect corporate governance and oversight—especially the Compensation and Nominating/Corporate Governance Committees.
• Mr. Hykes brings senior commercial and executive experience in medical device companies, which may influence the Board’s experience mix and oversight of strategy for a medical-device-focused company like Shoulder Innovations.
• The company explicitly noted the resignation was not due to disagreements with management or the Board, which investors often view as a stabilizing detail about governance continuity.